ライフサイエンスコーパス: clonidine

1 2A and alpha2C, and the 125I-labeled agonist clonidine.

2 normoxic, hypoxic, and hypoxic-treated with clonidine.

3 rawal treatment with either buprenorphine or clonidine.

4 d by the selective alpha2 adrenergic agonist clonidine.

5 dose-dependently by perineural injection of clonidine.

6 intraarterial infusions of phenylephrine and clonidine.

7 agonist phenylephrine and the alpha2-agonist clonidine.

8 increased resistance to M. avium induced by clonidine.

9 sed resistance to M. avium growth induced by clonidine.

10 Pertussis toxin blocked the effect of clonidine.

11 role in the analgesic effect of intrathecal clonidine.

12 mediates the analgesic effect of intrathecal clonidine.

13 thoroughly the neuroprotective properties of clonidine.

14 idine orally; or combined nitroglycerin plus clonidine.

15 was not reduced by peripheral or intra-BSTv clonidine.

16 dies provided data for midazolam and two for clonidine.

17 ll as the adrenergic alpha2 receptor agonist clonidine.

18 Clonidine (0.003-0.1 mg/kg, i.p.) dose-dependently atten

19 he intracerebroventricular (ICV) infusion of clonidine (0.03 microgram) caused an increase in NO conc

20 hibited by pretreatment with a fixed dose of clonidine (0.15 mg/kg, s.c.).

21 , patients were randomly assigned to receive clonidine (0.2 mg per day) or placebo just before surger

22 uring iontophoresis of phenylephrine (PE) or clonidine (0.5 mm, seven 0.1 mA pulses followed by one 0

23 interval [CI], -1.70 to -0.57), 4 trials of clonidine (-0.95; 95% CI, -1.44 to -0.47), and 2 trials

24 Oral clonidine, 0.1 mg/d, is effective against tamoxifen-indu

25 Sheep were treated with clonidine (1 mug/kg/hr) or saline-vehicle from 24 to 32

26 cardiac rate, followed by administration of clonidine (1.0 mg/kg).

27 Nanoinjection of the alpha2-AR agonist clonidine (1.2 nmol) into the rostral raphe pallidus are

28 367 and 339, respectively; hazard ratio with clonidine, 1.08; 95% confidence interval [CI], 0.93 to 1

29 Furthermore, the general alpha2-AR agonist clonidine (10 muM) failed to affect sIPSC frequency.

30 onists dexmedetomidine (25 mug/kg, i.v.) and clonidine (100 mug/kg, i.v.) inhibited shivering EMGs, B

31 nylephrine (-11 +/- 4 versus -39 +/- 4%) and clonidine (-12 +/- 4 versus -38 +/- 5%; all P < 0.005) w

32 enylephrine (-3 +/- 3 versus -28 +/- 4%) and clonidine (-15 +/- 4 versus -26 +/- 3%; all P < 0.05).

33 henylephrine (-12 +/- 8 vs. -37 +/- 8 %) and clonidine (-17 +/- 6 vs. -49 +/- 4 %) were significantly

34 lysaccharide, 10.7 [95% CI, 9.9-11.6]; after clonidine, 17.5 [95% CI, 16.7-18.4]).

35 thylphenidate (11.1); antidepressants (3.2); clonidine (2.3); and neuroleptics (0.9).

36 saline, dexmedetomidine (100 mug/kg IV), or clonidine (200 mug/kg IV).

37 tly studied and efficacious medications were clonidine (22 studies; risk ratio: 1.6, numbers needed t

38 older men, but did attenuate the response to clonidine (-22 +/- 3 versus -37 +/- 6%; P < 0.05).

39 -day naltrexone (0.01-0.1 mg/kg/h) and 7-day clonidine (3.2-10 mug/kg/h) treatment effects were also

40 Conscious rats received saline, clonidine (30 microg/kg, i.v.), saline plus sodium nitro

41 eatment (72%) relative to those who received clonidine (39%) (P<.05).

42 iglets that were in the Hx+Cl group received clonidine 5 min prior to hypoxia.

43 In vitro stimulation of the NTS with clonidine (50 nmol/L) resulted in an increase in the NO

44 pants choosing naltrexone therapy within the clonidine (8 [22.2%]), tramadol ER (7 [19.4%]), or bupre

45 Clonidine, a readily available medication, is useful in

46 In contrast, clonidine-activated alpha(2A)AR were switched by voltage

47 , studies were designed to ascertain whether clonidine acts as a free radical scavenger.

48 These results suggest that pre-operative clonidine administration could be a useful supplement to

49 the present study tests the hypothesis that clonidine administration will block increased nuclear Ca

50 After clonidine administration, growth hormone rose in PSP sub

51 Clonidine alone had no effect, but when administered fol

52 release), phenylephrine (alpha1-agonist) and clonidine (alpha2-agonist) were assessed.

53 henylephrine (selective alpha1-agonist), and clonidine (alpha2-agonist) were determined in 10 young (

54 ether the increase in decisiveness driven by clonidine also entails changes in hippocampal search pro

55 Clonidine also increased the production of ONOO(-) in M.

56 Clonidine also induced lower levels of NE release in the

57 Systemic clonidine also prevented the stress-associated increase

58 tions in the LH of two inhibitory compounds, clonidine (an alpha-2 adrenergic agonist) and muscimol (

59 ease), phenylephrine (an alpha1 agonist) and clonidine (an alpha2 agonist) in 10 healthy men during r

60 This study tests whether clonidine, an alpha(2)-adrenergic receptor agonist, alte

61 These effects were all mimicked by clonidine, an alpha-2 receptor agonist.

62 , including peripheral nerve block or spinal clonidine, an alpha2-adrenergic agonist.

63 Significance statement: Clonidine, an alpha2-adrenergic receptor agonist, which

64 ns had a higher spontaneous firing rate, and clonidine-an alpha2A-adrenergic agonist-inhibited LC neu

65 he effect of noradrenaline was reproduced by clonidine and antagonized by yohimbine, consistent with

66 -dependent adolescents relative to combining clonidine and behavioral interventions.

67 vitro data were generally in agreement that clonidine and bFGF counteracted the effect of NMDA as wo

68 gest that tramadol ER is more effective than clonidine and comparable to buprenorphine in reducing op

69 Clonidine and dexmedetomidine have many similar or super

70 rting the widespread use of alpha2 agonists (clonidine and dexmedetomidine) in pediatric critical car

71 in native sympathetic neurons in response to clonidine and guanfacine, two drugs used for treatment o

72 occurred in 329 patients (6.6%) assigned to clonidine and in 295 patients (5.9%) assigned to placebo

73 opioids as adjuncts are being challenged by clonidine and ketamine, which have more benign side effe

74 and alpha2-adrenergic receptor agonists (eg, clonidine and lofexidine).

75 Clonidine and nitroglycerin increased gastric compliance

76 amines and diphenhydramine; second, miosis - clonidine and opioids; third, nystagmus - dextromethorph

77 scending doses of oral naltrexone along with clonidine and other adjunctive medications.

78 ommonly experienced by patients treated with clonidine and other imidazoline-related drugs.

79 is necessary for the hypotensive effects of clonidine and other sympathoinhibitory adrenergic agonis

80 Thus, clonidine and oxymetazoline behaved as partial agonists.

81 Gialpha1 increased the relative efficacy of clonidine and oxymetazoline such that the two ligands no

82 The alpha agonists clonidine and phenylephrine both inhibited the potassium

83 In 16 other healthy subjects, the effects of clonidine and placebo on gastric emptying of solids were

84 y acting alpha2-adrenergic receptor agonist, clonidine), and hypoxia and sympathetic inhibition.Oxyha

85 g sedative premedications such as midazolam, clonidine, and dexmedetomidine.

86 The SSRIs or SNRIs, clonidine, and gabapentin trials provide evidence for ef

87 for neuropathic pain (ketamine, gabapentin, clonidine, and lidocaine), nociceptive pain (ketoprofen,

88 sed to treat vasovagal syncope (propranolol, clonidine, and paroxetine) in a double-blind crossover s

89 ing exercise and is reversed by propranolol, clonidine, and paroxetine.

90 f ethanol, oxotremorine, nicotine, baclofen, clonidine, and the cannabinoid receptor agonist WIN 55,2

91 Since this treatment completely antagonized clonidine antinociception (40 microg, i.c.v.), supraspin

92 2 channels in mutant mice largely eliminated clonidine antinociception and significantly decreased mo

93 The protective effect of 0.5% clonidine appeared to be greater when topically applied

94 8-day-old rats whether these 2 responses to clonidine are causally related.

95 Alpha-2 adrenoceptor agonists (e.g., clonidine) are effective at preventing many of the behav

96 ties of alpha(2)-adrenoceptor agonists, like clonidine, are very different from betaxolol.

97 a cellular substrate for the clinical use of clonidine as a treatment for hypertension as well as a r

98 likely that the use of epidural ketamine or clonidine as adjuncts to local anaesthetics will grow.

99 Clonidine, as compared with placebo, did not reduce the

100 Clonidine, as compared with placebo, was associated with

101 .1.1.28) and as inhibitors of the binding of clonidine at the alpha(2)-adrenoceptor.

102 injection of the alpha2-adrenoceptor agonist clonidine at the site of peripheral nerve injury reduces

103 alpha(2)-adrenoceptor agonists, such as clonidine, attenuate hypoxia-induced damage to brain and

104 Clonidine attenuated the increases in c-fos in the mNTS

105 Low-dose clonidine attenuates sympathetic outflow and systemic in

106 action, and provide the first evidence that clonidine attenuates the expression of the closely linke

107 A/A condition, whereas silencing the LC with clonidine before placement in the A/B condition blocked

108 he presence and absence of a alpha2-agonist (clonidine), beta-adrenergic receptor antagonist (propran

109 ailed to show displacement of specific [(3)H]clonidine binding to rat brain membranes for either comp

110 The authors tested whether clonidine blocks stress-induced seeking of heroin and co

111 The fact that both betaxolol and clonidine blunt hypoxia-induced death to retinal ganglio

112 Clonidine but not nitroglycerin reduced aggregate and pa

113 with oestrogen, gabapentin, paroxetine, and clonidine, but little or no benefit with other agents; a

114 Moreover, i.p. injection of clonidine, but not betaxolol, elevated bFGF mRNA levels

115 em to mediate the antinociceptive effects of clonidine, but not that produced by improgan.

116 Statins, beta-blockers, and clonidine can potentially improve long-term cardiac risk

117 Administration of perioperative clonidine can reduce the risk of perioperative myocardia

118 This ICV injection of clonidine caused a fall in mean arterial pressure of -22

119 rgic agonists (phenylephrine (PE), alpha(1); clonidine (CL), alpha(2)).

120 deltorphin II (DELT), the alpha(2)AR agonist clonidine (CLON) or their combination to inhibit calcito

121 Clonidine (CLON), an alpha-2 agonist, has anxiolytic-lik

122 0.5 mg/kg BW), an alpha2-adrenergic agonist, clonidine (CLON; 0.6 mg/kg BW), or a beta-adrenergic ago

123 microinfusions (1 mul) of the alpha2 agonist clonidine (CLON; 1.32 nmol), and half received the alpha

124 Perioperative clonidine comes in a patch form that can be used in pati

125 nists such as oxymetazoline, cirazoline, and clonidine, confirming previous evidence that this class

126 ine and synaptic transmission was reduced by clonidine, consistent with an action at presynaptic alph

127 ulation of the release of NO in the brain by clonidine contributes to its central antihypertensive ac

128 thesized that the anxiolytic-like actions of clonidine could be mimicked by stimulation of alpha-2 re

129 NE and clonidine decreased calcium currents evoked by depolariz

130 The roles of clonidine, dexmedetomidine, ketamine and nalbuphine in t

131 Clonidine did not affect basal [(3)H]cAMP levels, but at

132 Although NO production was required, clonidine did not increase the level of NO in M. avium-i

133 ous ligand(s) for imidazoline binding sites, clonidine-displacing substance (CDS), has been a major g

134 Administration of clonidine during hypotensive sepsis reduced renal sympat

135 or antagonists (atropine and scopolamine) on clonidine-elicited nitrite release was more potent than

136 inic antagonists dose-dependently attenuated clonidine-elicited nitrite release.

137 Clonidine evoked a decrease in cRCF ( approximately 30%;

138 Clonidine evoked both increases and decreases in cRCF be

139 idazoxan (6 nmol) into the rRPa reversed the clonidine-evoked inhibition of BAT SNA and BAT thermogen

140 arinic and nicotinic receptor antagonists on clonidine-evoked nitrite (a stable product of NO) releas

141 e present study, we tested a hypothesis that clonidine-evoked NO release is dependent primarily on mu

142 Ineffective drugs included clonidine, flunarizine, pizotifen, propranolol, and valp

143 dition, iontophoresis of the alpha-2 agonist clonidine, footshock administration, and LC stimulation

144 s before the clonidine) reduced responses to clonidine for both mean arterial pressure and heart rate

145 nd epidural ones, as well as the addition of clonidine for peripheral neural blockade, have been desc

146 have shown certain benefits from the use of clonidine for regional anesthesia, further investigation

147 Most authors agree that the use of clonidine for regional neural blockade in combination wi

148 itch was notably faster than dissociation of clonidine from alpha(2A)AR, indicating voltage-dependent

149 in quality-of-life scores (0.3 points in the clonidine group compared with -0.2 points in the placebo

150 During intervention, the clonidine group had a lower number of steps per day (mea

151 prenorphine condition and 5% of those in the clonidine group initiated treatment with naltrexone.

152 se in hot flash frequency was greater in the clonidine group than in the placebo group after 4 weeks

153 Significantly more patients in the clonidine group than in the placebo group had clinically

154 group difference in time to relapse, but the clonidine group took longer to lapse (hazard ratio=0.67,

155 partly decoupled from opioid craving in the clonidine group, supporting the authors' hypothesized me

156 Propranolol and clonidine had no significant effect on SBP during exerci

157 Background- Clonidine has an antihypertensive effect by its action i

158 Clonidine has been used for many purposes, including red

159 Clonidine has recently been used as a pre-operative medi

160 re therefore undertaken to determine whether clonidine has similar properties.

161 Perioperative clonidine has some advantages over perioperative beta-bl

162 Clonidine hydrochloride capsules (25 microg or 50 microg

163 Oral clonidine hydrochloride, 0.1 mg/d, or placebo for 8 week

164 Administration of low-dose clonidine in patients undergoing noncardiac surgery did

165 The latest articles describing the use of clonidine in regional anesthesia are discussed.

166 dazol-2-yl)-6-quinoxalinamine (UK14,304) and clonidine in spinophilin-null mice.

167 se findings, a clinical trial for the use of clonidine in the treatment of persistent vasopressor-ref

168 effect of the alpha(2)-adrenoceptor agonist clonidine in this rat model.

169 BB NHE3 exists in lipid rafts; (ii) EGF and clonidine increase the amount of BB NHE3; (iii) lipid ra

170 mans, the alpha2-adrenergic receptor agonist clonidine increases decisiveness in tasks that require p

171 Prolonged treatment with either DAMGO or clonidine induced a mutual cross-desensitization between

172 pha(2)-adrenergic agonist (alpha(2)-agonist) clonidine induced resistance to M. avium growth in the R

173 uble NHE3 pool, are involved in the EGF- and clonidine-induced acute increase in amount of BB NHE3; (

174 Clonidine-induced alpha(2A)AR desensitization, but not r

175 urthermore, the more pronounced morphine and clonidine-induced antinociception in male mice disappear

176 Based on the almost complete loss of clonidine-induced antinociception in the mutant mice, we

177 This EGF- and clonidine-induced increase of BB NHE3 was associated wit

178 nic, as well as nicotinic, receptors mediate clonidine-induced NO release in the spinal cord.

179 ce has indicated that a key mechanism of the clonidine-induced reversal of the effects of NMDA antago

180 Prenalterol pretreatment suppressed clonidine-induced ultrasound production at both doses.

181 2 mild hyperthermia significantly inhibited clonidine-induced ultrasound production.

182 Noradrenaline or clonidine inhibited the capsaicin-activated current by a

183 ol5]enkephalin (DAMGO) or the alpha2 agonist clonidine inhibited voltage-gated Ca2+ currents in these

184 ese findings establish a causal link between clonidine inhibition of c-fos expression in brainstem an

185 No evidence could be found that clonidine interacts with sodium or L-type calcium channe

186 Clonidine is a partial alpha 2 adrenergic agonist that h

187 When clonidine is added to a fentanyl-bupivacaine mixture for

188 lts suggest that the decisiveness seen under clonidine is due to limited exploration of potential opt

189 logues of the alpha2 adrenergic agonist drug clonidine is elaborated.

190 Low-dose clonidine is not clinically useful in CFS.

191 ion of alpha(2) adrenergic agonists, such as clonidine, is capable of alleviating neuropathic pain.

192 egy is to combine adjuvants such as opioids, clonidine, ketamine and neostigmine to potentiate the ef

193 Researchers have speculated that clonidine limits the amount of mental search that subjec

194 We find that clonidine limits the options searched by rats, suggestin

195 However, the mechanisms by which clonidine makes them more decisive remain unknown.

196 Yohimbine antagonized the clonidine-mediated adenylyl cyclase inhibition.

197 H enhanced the alpha2-adrenoreceptor agonist clonidine-mediated inhibition (3 microM; NORM, 23 +/- 2%

198 he presence of the NO donor spermine-NO, the clonidine-mediated inhibition of forskolin- and isoprote

199 Clonidine, meperidine, tramadol, nefopam, and ketamine w

200 lammatory agents, anticonvulsants, ketamine, clonidine, mexiletine, antidepressants, and anxiolytics

201 cerebroventricularly applied agonists (NMDA, clonidine, muscimol, and baclofen) at several types of r

202 A 7-day taper using clonidine (n = 36), tramadol ER (n = 36), or buprenorphi

203 angiotensin-converting-enzyme inhibitors, or clonidine (n=15,044), those assigned calcium antagonists

204 prenorphine and randomly assigned to receive clonidine (N=61) or placebo (N=57) for 14 weeks.

205 ase alpha2-adrenergic agonists guanfacine or clonidine (no studies).

206 failure etiology, ventilation duration, and clonidine (odds ratio [OR] = 2.14; 95% confidence interv

207 nts 1 and 2 prevent or dampen the effects of clonidine on cardiac rate.

208 cavenger of ONOO(-), inhibited the effect of clonidine on M. avium growth.

209 the effects of the alpha2-adrenergic agonist clonidine on mean arterial pressure, renal sympathetic n

210 role in the analgesic effect of intrathecal clonidine on neuropathic pain.

211 search processes, we compared the effect of clonidine on spatial representations in hippocampal neur

212 The present study investigated the effect of clonidine on the basal and inducible c-jun and c-fos mRN

213 aken to determine whether i.p. injections of clonidine or betaxolol affect retinal bFGF mRNA levels.

214 awal (ie, detoxification) from opioids using clonidine or buprenorphine hydrochloride is a widely use

215 Here, we test this hypothesis using clonidine or guanfacine (GFC), another alpha-2 agonist,

216 In contrast, the adrenergic agonists clonidine or norepinephrine, and the K(ATP) channel inhi

217 re randomized 1:1 to treatment with low-dose clonidine or placebo for 9 weeks and monitored for 30 we

218 plications to receive aspirin or placebo and clonidine or placebo.

219 nous nitroglycerin; 0.0125, 0.025, or 0.1 mg clonidine orally; or combined nitroglycerin plus clonidi

220 ipants, surgeons, and sedationists preferred clonidine over the placebo.

221 (AR) transfectants, the alpha(2)-AR agonists clonidine, oxymetazoline, UK-14304, and epinephrine incr

222 tained at the end of the taper compared with clonidine participants (22 [61.1%]); tramadol ER retenti

223 isfaction in the group of patients receiving clonidine plus morphine.

224 ), saline plus sodium nitroprusside (NP), or clonidine plus NP.

225 tment (0.03-0.15 mg/kg, s.c.) and reduced by clonidine posttreatment (0.15 mg/kg, s.c.).

226 Clonidine pre-treatment increased and prolonged sedation

227 trial, we characterized the effects of oral clonidine pre-treatment on intravenous diazepam/meperidi

228 s also inhibited in a dose-related manner by clonidine pretreatment (0.03-0.15 mg/kg, s.c.) and reduc

229 Perineural clonidine prevented both the increase in leukocyte numbe

230 creased with hypoxia (137 +/- 13%; P =0.02); clonidine prevented the hypoxia induced increase (94 +/-

231 The data show that clonidine prevents hypoxia-induced increase in CaM KIV a

232 In an intent-to-treat analysis, clonidine produced the longest duration (in consecutive

233 suggest that while most of topically applied clonidine reaches the retina by a systemic route one can

234 rgic (phenylephrine) and alpha 2-adrenergic (clonidine) receptor stimulation were blunted during mode

235 d opioid (morphine) and alpha(2)-adrenergic (clonidine) receptor-induced antinociception in a spinal

236 Additionally, clonidine reduced the capacity of leukocytes to express

237 Similarly, clonidine reduced the frequency of capsaicin-induced mEP

238 In spinal cord slices, clonidine reduced the frequency of capsaicin-induced min

239 Clonidine reduced the number of macrophages and lymphocy

240 cromol; delivered ICV, 30 minutes before the clonidine) reduced responses to clonidine for both mean

241 ne, ketamine, dexmedetomidine, propofol, and clonidine) reduced the risk of delirium (relative risk,

242 nd the alpha(2)-adrenergic receptor agonist, clonidine, reduced the number of Fos-li dopaminergic neu

243 ngs should be reconciled with the absence of clonidine-related GH blunting in the same cohort.

244 activation of adrenergic alpha2 receptors by clonidine represents a double-hit to pancreatic islets t

245 determine whether the hypotensive action of clonidine resulted from its stimulation of excess NO in

246 of patients' stress to test hypotheses about clonidine's behavioral mechanism of action.

247 ting the authors' hypothesized mechanism for clonidine's benefits.

248 These results suggest that clonidine's effect on ultrasound production is mediated

249 Short-acting clonidine should be avoided because of rebound hypertens

250 Clonidine significantly increased the numbers of BIS-dep

251 Clonidine significantly inhibited GABAergic neurotransmi

252 ising for the treatment of gastroparesis are clonidine, sildenafil, and intrapyloric botulinum toxin.

253 istration of the alpha2 adrenoceptor agonist clonidine simultaneously evokes ultrasound production an

254 e include a belladonna alkaloid preparation, clonidine, soy phyto-oestrogens, vitamin E, gabapentin,

255 P < .001) from stabilization to taper in the clonidine (stabilization mean, 0.64 [SE, .05]; taper mea

256 between 1991 and 1995 across the 3 sites for clonidine, stimulants, and antidepressants, while neurol

257 Clonidine suppressed SNA and abolished all arrhythmias.

258 Injection of clonidine suppressed the spatial representation of the u

259 between the taper and post-taper periods for clonidine (taper mean, 13.1; post-taper mean, 3.2; P < .

260 The response to growth hormone-clonidine testing, a neuropharmacological assessment of

261 ogram, while the HMO had nearly 3 times more clonidine than antidepressant use (1.9 vs 0.7).

262 ion and endocytosis of alpha(2A)AR evoked by clonidine than by guanfacine.

263 nsitization of Ca(2+) current suppression by clonidine than guanfacine, which paralleled a more marke

264 dentified a second-line agent, perioperative clonidine, that can be used to reduce the risk of periop

265 r harmane, the alpha(2)-adrenoceptor agonist clonidine, the mu-opioid receptor agonists morphine and

266 ed in anesthesia and pain management include clonidine, tizanidine, and dexmedetomidine.

267 The addition of clonidine to intravenous regional anesthesia resulted in

268 no difference in onset time.The addition of clonidine to the local anesthetic opioid mixtures seems

269 Clonidine treatment prevented the further decline in mea

270 Clonidine treatment significantly increased fentanyl-vs.

271 ring amphetamine injections and abolished by clonidine treatment.

272 Both EGF and clonidine treatments were associated with a rapid increa

273 a trial was planned to compare midazolam and clonidine, two sedatives widely used within PICUs neithe

274 In another study, the effects of clonidine used for intra-articular administration in com

275 ign to allow separate evaluation of low-dose clonidine versus placebo and low-dose aspirin versus pla

276 son of the dynamics of voltage-dependence of clonidine- vs. norepinephrine-activated receptors uncove

277 owed that co-administration of rapamycin and clonidine was associated with an increased incidence of

278 The protective effect of clonidine was attenuated when the alpha(2)-adrenoceptor

279 These changes were blunted when clonidine was injected intraperitoneally before or after

280 mplete spinalization (T13) was performed and clonidine was injected to induce rhythmic activities.

281 No dose effect of clonidine was observed on gastric emptying.

282 Less clear results were seen when clonidine was used for caudal anesthesia in a pediatric

283 pidural analgesia using levobupivacaine with clonidine was used in patients undergoing total hip arth

284 The higher doses of clonidine were associated with a more cephalad spread of

285 Patients receiving clonidine were more likely than patients receiving place

286 ly, the electrographic responses to NMDA and clonidine were potentiated, whereas the ECoG effects med

287 All of the effects of clonidine were prevented by coadministration of an alpha

288 The effects of clonidine were prevented by the alpha-2A subtype selecti

289 or responses in the leg to phenylephrine and clonidine were similar (or enhanced) postexercise vs. pr

290 esponses in the forearm to phenylephrine and clonidine were similar (or enhanced) postexercise vs. pr

291 for older versus young men, respectively) to clonidine were similar in the 2 groups.

292 ansmission, the effects of noradrenaline and clonidine were tested on the capsaicin-activated current

293 and apraclonidine, acted in a similar way to clonidine when applied topically but because of the numb

294 assessed if the alpha2-autoreceptor agonist clonidine (which decreases norepinephrine release) would

295 Low-dose clonidine, which blunts central sympathetic outflow, may

296 exposed embryos to the drugs epinephrine and clonidine, which increased or decreased heart rate, resp

297 blocked the increased resistance induced by clonidine, while a Gs-protein antagonist was without eff

298 cts were identified for midazolam and 16 for clonidine with full texts obtained for 80 and 6 articles

299 For the comparison of clonidine with placebo, patients were randomly assigned

300 after exposure to forskolin, isoproterenol, clonidine, yohimbine, pertussis toxin, and the NO donor